ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOKANDO CO.,LTD.
  3. Financials
  4. Property, plant and equipment, net

KOKANDO CO.,LTD. (E00959)

Market cap
P/E ratio
Kokan-do manufactures over-the-counter medicines like cold and stomach remedies, blending Toyama's traditional medicine heritage with modern pharmaceutical operations.
SummaryFinancialsDividendsHistoryWorkforce
Period EndProperty, plant and equipment, net (Million JPY)YoY (%)
Mar 31, 202511,768+1.84%
Mar 31, 202411,555-6.33%
Mar 31, 202312,336-3.18%
Mar 31, 202212,741+23.61%
Mar 31, 202110,308+6.99%
Mar 31, 20209,635-0.92%
Mar 31, 20199,724-8.05%
Mar 31, 201810,575-10.95%
Mar 31, 201711,876-8.93%
Mar 31, 201613,040-2.68%
Mar 31, 201513,400

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat